Cargando…

Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease

Naltrexone is an approved drug for management of alcohol use disorder (AUD), but data in patients with liver disease (LD) are limited. We aimed to evaluate the safety of naltrexone in those with LD. This is a retrospective cohort of adults with and without LD who were prescribed naltrexone for AUD f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayyala, Divya, Bottyan, Thomas, Tien, Christine, Pimienta, Michael, Yoo, Jennie, Stager, Kelli, Gonzalez, Jose Luis, Stolz, Andrew, Dodge, Jennifer L., Terrault, Norah A., Han, Hyosun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701476/ https://www.ncbi.nlm.nih.gov/pubmed/36281979 http://dx.doi.org/10.1002/hep4.2080

Ejemplares similares

The Internet as a Tool for Liver Transplant Programs to Combat Stigma Related to Alcohol Use Disorder
por: Pimienta, Michael, et al.
Publicado: (2021)

Liver transplant for alcohol-associated liver disease continues to rise 2 years into the COVID-19 pandemic especially among young adults
por: Lee, Brian P., et al.
Publicado: (2023)

Naltrexone and the Treatment of Alcohol Dependence
por: Volpicelli, Joseph R., et al.
Publicado: (1994)

Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use
por: Hahn, Judith A., et al.
Publicado: (2023)

Evaluating Women’s Preferences for Hepatitis C Treatment During Pregnancy
por: Kushner, Tatyana, et al.
Publicado: (2018)

Hepatitis C elimination: challenges with under-diagnosis and under-treatment
por: Terrault, Norah A
Publicado: (2019)

Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care
por: Kushner, Tatyana, et al.
Publicado: (2018)

Racial and ethnic differences in diet quality and food insecurity among adults with fatty liver and significant fibrosis: a U.S. population‐based study
por: Kardashian, Ani, et al.
Publicado: (2022)

Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans
por: Leighty, Anne E., et al.
Publicado: (2019)

Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
por: Galloway, Gantt P, et al.
Publicado: (2005)

Medicaid expansion and variability in mortality in the USA: a national, observational cohort study
por: Lee, Brian P, et al.
Publicado: (2022)

Disparities in presentation and management of chronic hepatitis B among Hispanics in a diverse safety net system
por: Wang, Allison E., et al.
Publicado: (2023)

Naltrexone long-acting formulation in the treatment of alcohol dependence
por: Johnson, Bankole A
Publicado: (2007)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Views about responsibility for alcohol addiction and negative evaluations of naltrexone
por: Johnson, Rebecca A, et al.
Publicado: (2015)

Naltrexone ameliorates functional network abnormalities in alcohol‐dependent individuals
por: Morris, Laurel S., et al.
Publicado: (2017)

Naltrexone-induced psychosis in a patient with alcohol use disorder
por: Ruei-Yuan, Hu, et al.
Publicado: (2023)

A comparative study on the safety and efficacy of naltrexone versus baclofen versus acamprosate in the management of alcohol dependence
por: Kumar, Arun, et al.
Publicado: (2020)

Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol‐associated hepatitis
por: Lee, Brian P., et al.
Publicado: (2022)

Predictors of Interest in an Alcohol Reduction Clinical Trial of Naltrexone among Undergraduates
por: Leeman, Robert F, et al.
Publicado: (2013)

Prevention of Hepatitis C in Women
por: Bell, Beth P., et al.
Publicado: (2004)

O-Benzoylnaltrexone
por: Yang, Rui, et al.
Publicado: (2013)

Asymmetric synthesis of (–)-naltrexone
por: Dongbang, Sun, et al.
Publicado: (2018)

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
por: Colquhoun, Ross M.
Publicado: (2013)

The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study
por: Ray, Lara A., et al.
Publicado: (2010)

Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review
por: Ahmed, Rizwan, et al.
Publicado: (2018)

Effectiveness of naltrexone treatment for alcohol use disorders in HIV: a systematic review
por: Farhadian, Negin, et al.
Publicado: (2020)

Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane
por: Terenius, Lars, et al.
Publicado: (2023)

Naltrexone‐induced drug eruption
por: Heck, Johannes, et al.
Publicado: (2020)

Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats
por: Momeni, Shima, et al.
Publicado: (2015)

Effects of naltrexone on alcohol self‐administration and craving: meta‐analysis of human laboratory studies
por: Hendershot, Christian S., et al.
Publicado: (2016)

FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study
por: Bach, Patrick, et al.
Publicado: (2021)

Baclofen and naltrexone, but not N-acetylcysteine, affect voluntary alcohol drinking in rats regardless of individual levels of alcohol intake
por: Minnaard, A. Maryse, et al.
Publicado: (2020)

Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder
por: Castaldelli-Maia, João M., et al.
Publicado: (2021)

Clinical Efficacy and Safety of Naltrexone Combination Therapy in Older Patients with Severe Pruritus
por: Lee, Jungsoo, et al.
Publicado: (2016)

Safety and efficacy of naltrexone for weight loss in adult patients – a systematic review
por: Kulak-Bejda, Agnieszka, et al.
Publicado: (2020)

The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review
por: Yang, Juan, et al.
Publicado: (2023)

Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B
por: Choi, Hannah S.J., et al.
Publicado: (2021)

Commentary: Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats
por: Kalueff, Allan V.
Publicado: (2016)

Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes
por: Kirchoff, Robert W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gne430p8pkduitioojl3odvui7